The company's mission is to improve the lives of patients with skin diseases such as acne, psoriasis, and atopic dermatitis, by providing new treatment options that are currently inadequately addressed or burdened with side effect profiles. Botanix is utilizing the potential of synthetic cannabidiol, a pharmaceutical ingredient currently being studied for various indications, to develop a proprietary drug delivery system (PermetrexTM) for direct skin delivery of the therapy. The company is committed to ethical research and development and the highest clinical standards mandated by the US FDA, with the goal of unlocking the true potential of synthetic cannabinoids for people worldwide.